RETRACTED ARTICLE: Mirt2 functions in synergy with miR-377 to participate in inflammatory pathophysiology of Sjögren's syndrome

Abstract Background The interaction of long non-coding RNAs (lncRNAs)-microRNAs (miRs) exerts crucial functions in mediating inflammatory reaction. It is still unclear whether myocardial infarction associated transcript 2 (Mirt2)-miR-377 mediates the inflammatory pathogenesis in Sjögren's syndrome (SS). Methods The inflammatory lesion model was established by stimulating salivary gland epithelial cells (SGECs) by interferon gamma (IFN-γ). Mirt2- and/or miR-377-transfected SGECs, as well as their negative controls, were applied to investigate the biological functions in inflammation. Cell viability and apoptosis were examined using commercial kits. Western blot was applied to quantify protein level, and enzyme-linked immuno sorbent assay (ELISA) was used to value the secretion of cytokines. Results The up-regulation of Mirt2 was observed in IFN-γ-treated SGECs. Mirt2 overexpression restored the expression of miR-377 which was repressed by IFN-γ. However, miR-377 silence abolished the protective effect on cell viability, inhibitory effect on apoptosis and prohibitive role in pro-inflammatory factors. Mirt2 diminished the phosphorylated expression of crucial regulators while miR-377 silence restored the phosphorylation in IFN-γ-treated SGECs. Conclusion Mirt2 was elevated in IFN-γ-treated SGECs and then up-regulated miR-377 in response to inflammatory lesions. Mechanically, in synergy with miR-377 Mirt2 blocked IFN-γ-evoked activation of NF-κB and JAK/STAT signalling pathway.

[1]  Y. Liu,et al.  Down-regulation of miR-377 suppresses high glucose and hypoxia-induced angiogenesis and inflammation in human retinal endothelial cells by direct up-regulation of target gene SIRT1 , 2019, Human Cell.

[2]  M. Jagodic,et al.  miR‐31 regulates energy metabolism and is suppressed in T cells from patients with Sjögren's syndrome , 2018, European journal of immunology.

[3]  Jae-Woong Min,et al.  JAK‐1 Inhibition Suppresses Interferon‐Induced BAFF Production in Human Salivary Gland , 2018, Arthritis & rheumatology.

[4]  Zhiming Liu,et al.  A study on the mechanism of agonists in regulating transcriptional level of pIgR in salivary gland epithelial cells , 2018, Experimental and therapeutic medicine.

[5]  E. Tinazzi,et al.  Long Non-Coding RNAs Play a Role in the Pathogenesis of Psoriatic Arthritis by Regulating MicroRNAs and Genes Involved in Inflammation and Metabolic Syndrome , 2018, Front. Immunol..

[6]  E. Costantini,et al.  MicroRNA in Sjögren's Syndrome: Their Potential Roles in Pathogenesis and Diagnosis , 2018, Journal of immunology research.

[7]  Xiangcui Ding,et al.  miR-377 targets CUL4A and regulates metastatic capability in ovarian cancer , 2018, International journal of molecular medicine.

[8]  Xiang-Hu He,et al.  LncRNA MALAT1 regulates sepsis‐induced cardiac inflammation and dysfunction via interaction with miR‐125b and p38 MAPK/NF&kgr;B , 2018, International immunopharmacology.

[9]  Min Liu,et al.  miR‐377‐3p drives malignancy characteristics via upregulating GSK‐3β expression and activating NF‐κB pathway in hCRC cells , 2018, Journal of cellular biochemistry.

[10]  B. Zhao,et al.  MiR‐377 Regulates Inflammation and Angiogenesis in Rats After Cerebral Ischemic Injury , 2018, Journal of cellular biochemistry.

[11]  D. Thanos,et al.  Impaired anti-inflammatory activity of PPARγ in the salivary epithelia of Sjögren's syndrome patients imposed by intrinsic NF-κB activation. , 2018, Journal of autoimmunity.

[12]  Kun Huang,et al.  The LPS-inducible lncRNA Mirt2 is a negative regulator of inflammation , 2017, Nature Communications.

[13]  S. Zeinali,et al.  MiR-377 reverses cancerous phenotypes of pancreatic cells via suppressing DNMT1 and demethylating tumor suppressor genes. , 2017, Epigenomics.

[14]  Jian Peng,et al.  MiR-377 promotes white adipose tissue inflammation and decreases insulin sensitivity in obesity via suppression of sirtuin-1 (SIRT1) , 2017, Oncotarget.

[15]  Chuangqi Yu,et al.  Long non-coding RNA expression profile in minor salivary gland of primary Sjögren’s syndrome , 2016, Arthritis Research & Therapy.

[16]  M. Bubb,et al.  Sjögren’s syndrome-associated microRNAs in CD14+ monocytes unveils targeted TGFβ signaling , 2016, Arthritis Research & Therapy.

[17]  Huaxi Xu,et al.  Upregulation of long noncoding RNA TMEVPG1 enhances T helper type 1 cell response in patients with Sjögren syndrome , 2016, Immunologic research.

[18]  V. Scaria,et al.  Long noncoding RNAs could be potential key players in the pathophysiology of Sjögren's syndrome , 2015, International journal of rheumatic diseases.

[19]  A. Martí,et al.  Noncoding RNAs, cytokines, and inflammation‐related diseases , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  Jian-Mei Li,et al.  Pterostilbene and allopurinol reduce fructose-induced podocyte oxidative stress and inflammation via microRNA-377. , 2015, Free radical biology & medicine.

[21]  H. Schayek,et al.  MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma , 2015, Molecular Cancer.

[22]  Zhi-ping Chen,et al.  RP5-833A20.1/miR-382-5p/NFIA–Dependent Signal Transduction Pathway Contributes to the Regulation of Cholesterol Homeostasis and Inflammatory Reaction , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[23]  XinMa,et al.  RP5-833A20.1/miR-382-5p/NFIA–Dependent Signal Transduction Pathway Contributes to the Regulation of Cholesterol Homeostasis and Inflammatory Reaction , 2015 .

[24]  Lu Zhang,et al.  Identification of candidate long non-coding RNAs in response to myocardial infarction , 2014, BMC Genomics.

[25]  C. Wahlestedt.  Targeting long non-coding RNA to therapeutically upregulate gene expression , 2013, Nature Reviews Drug Discovery.

[26]  John D. Minna,et al.  miR-337-3p and Its Targets STAT3 and RAP1A Modulate Taxane Sensitivity in Non-Small Cell Lung Cancers , 2012, PloS one.

[27]  M. Sisto,et al.  Sjögren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κB , 2012, Laboratory Investigation.

[28]  S. Raimondo,et al.  Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjögren's syndrome , 2011, Annals of the rheumatic diseases.

[29]  C. Lucchesi,et al.  Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Brayer,et al.  A Dual Role for Interferon‐γ in the Pathogenesis of Sjögren's Syndrome‐Like Autoimmune Exocrinopathy in the Nonobese Diabetic Mouse , 2004, Scandinavian journal of immunology.